VivoSim Labs Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About VivoSim Labs Inc
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
/ 
Frequently asked questions
To buy VivoSim Labs Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for VivoSim Labs Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for VivoSim Labs Inc is VIVS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
VivoSim Labs Inc has its primary listing on NASDAQ. You can trade VivoSim Labs Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, VivoSim Labs Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include VivoSim Labs Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like VivoSim Labs Inc.